{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T16:07:04Z","timestamp":1792598824113,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Thyroid disorders are common in patients with autoimmune diseases such as rheumatoid arthritis (RA). Both conditions present significant public health concerns due to their impact on quality of life and increased mortality. The aim of this study was to assess the prevalence of thyroid abnormalities in and investigate their influence on rheumatoid arthritis characteristics. This was a case\u2013control study involving adult female patients with RA and age-matched healthy controls. RA disease activity was evaluated using the Disease Activity Score (DAS28), and functional impact was assessed using the Health Assessment Questionnaire (HAQ). Serum thyroid function tests were performed, including thyroid-stimulating hormone (TSH), free thyroxine (FT4), and antithyroid antibodies (TAAs), including anti-thyroglobulin antibodies (TgAb), anti-thyroperoxidase antibodies (TPOAb), and TSH receptor antibodies (TRAb). The study included 58 female RA patients, with a mean age of 52\u2009\u00b1\u200914.2\u00a0years. The median disease duration was 10.41\u00a0years. The median DAS28-CRP was 4.03, and the median HAQ was 1.34. The median FT4 and TSH levels were 15.01 [13.48;16.71] and 1.42 [0.91;2.26], respectively. Thyroid dysfunction was identified in 19% of the participants, with hypothyroidism being the most common disorder (17%). Hyperthyroidism was observed in 2% of patients. Antithyroid antibodies were positive in 15.5% (n\u2009=\u20099) of participants, with TPOAb present in 6 patients (10.3%), TgAb in 3 patients (5.2%), and TRAb in 2 patients (3.4%). No statistically significant association was found between thyroid status and RA disease activity, functional impact, or serological status. Despite the lack of correlation, the high prevalence of thyroid dysfunction underscores the importance of regular thyroid screening to optimize management and prognosis in RA patients.<\/jats:p>","DOI":"10.1038\/s41598-025-13650-8","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:58:59Z","timestamp":1759485539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Prevalence and impact of thyroid dysfunction in patients with rheumatoid arthritis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-8653","authenticated-orcid":false,"given":"Safa","family":"Rahmouni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8023-7096","authenticated-orcid":false,"given":"Malek","family":"Dhifallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8483-9927","authenticated-orcid":false,"given":"Mehdi","family":"Mrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3680-9918","authenticated-orcid":false,"given":"Eya","family":"Bouall\u00e8gue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0048-2428","authenticated-orcid":false,"given":"Khaoula","family":"Zouaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Krir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8524-6223","authenticated-orcid":false,"given":"Sonia","family":"Rekik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiba","family":"Wahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9185-1710","authenticated-orcid":false,"given":"Soumaya","family":"Boussaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8383-2707","authenticated-orcid":false,"given":"Hela","family":"Sahli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afef","family":"Bahlous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"issue":"9746","key":"13650_CR1","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","volume":"376","author":"DL Scott","year":"2010","unstructured":"Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376(9746), 1094\u20131108. https:\/\/doi.org\/10.1016\/S0140-6736(10)60826-4 (2010).","journal-title":"Lancet"},{"key":"13650_CR2","doi-asserted-by":"publisher","first-page":"799","DOI":"10.3389\/fendo.2018.00799","volume":"9","author":"Q Li","year":"2019","unstructured":"Li, Q. et al. Increased risk of thyroid dysfunction among patients with rheumatoid arthritis. Front. Endocrinol. 9, 799. https:\/\/doi.org\/10.3389\/fendo.2018.00799 (2019).","journal-title":"Front. Endocrinol."},{"issue":"3","key":"13650_CR3","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s10067-024-06888-6","volume":"43","author":"A Lichtiger","year":"2024","unstructured":"Lichtiger, A., Fadaei, G. & Tagoe, C. E. Autoimmune thyroid disease and rheumatoid arthritis: Where the twain meet. Clin. Rheumatol. 43(3), 895\u2013905. https:\/\/doi.org\/10.1007\/s10067-024-06888-6 (2024).","journal-title":"Clin. Rheumatol."},{"issue":"9","key":"13650_CR4","doi-asserted-by":"publisher","first-page":"18204","DOI":"10.7759\/cureus.18204","volume":"13","author":"K Nazary","year":"2021","unstructured":"Nazary, K. et al. Prevalence of thyroid dysfunction in newly diagnosed rheumatoid arthritis patients. Cureus 13(9), 18204. https:\/\/doi.org\/10.7759\/cureus.18204 (2021).","journal-title":"Cureus"},{"issue":"2","key":"13650_CR5","doi-asserted-by":"publisher","first-page":"001282","DOI":"10.1136\/rmdopen-2020-001282","volume":"6","author":"K Waldenlind","year":"2020","unstructured":"Waldenlind, K., Delcoigne, B., Saevarsdottir, S. & Askling, J. Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate?. RMD Open 6(2), 001282. https:\/\/doi.org\/10.1136\/rmdopen-2020-001282 (2020).","journal-title":"RMD Open"},{"issue":"7\u20138","key":"13650_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.20452\/pamw.1829","volume":"123","author":"A Koszarny","year":"2013","unstructured":"Koszarny, A., Majdan, M., Suszek, D., Wielosz, E. & Dryglewska, M. Relationship between rheumatoid arthritis activity and antithyroid antibodies. Pol. Arch. Med. Wewn. 123(7\u20138), 394\u2013400. https:\/\/doi.org\/10.20452\/pamw.1829 (2013).","journal-title":"Pol. Arch. Med. Wewn."},{"issue":"6","key":"13650_CR7","doi-asserted-by":"publisher","first-page":"26382","DOI":"10.7759\/cureus.26382","volume":"14","author":"A Zohaib","year":"2022","unstructured":"Zohaib, A. et al. Correlation of hypothyroidism with disease activity score-28 in patients of rheumatoid arthritis. Cureus 14(6), 26382. https:\/\/doi.org\/10.7759\/cureus.26382 (2022).","journal-title":"Cureus"},{"key":"13650_CR8","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.7717\/peerj.4216","volume":"6","author":"YL Chen","year":"2018","unstructured":"Chen, Y. L. et al. Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies. PeerJ 6, 4216. https:\/\/doi.org\/10.7717\/peerj.4216 (2018).","journal-title":"PeerJ"},{"issue":"1","key":"13650_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08916930701620100","volume":"41","author":"F Atzeni","year":"2008","unstructured":"Atzeni, F. et al. Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: Prevalence and clinical value. Autoimmunity 41(1), 111\u2013115. https:\/\/doi.org\/10.1080\/08916930701620100 (2008).","journal-title":"Autoimmunity"},{"issue":"4","key":"13650_CR10","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/BF02231775","volume":"12","author":"G Bianchi","year":"1993","unstructured":"Bianchi, G. et al. Thyroid involvement in chronic inflammatory rheumatological disorders. Clin. Rheumatol. 12(4), 479\u2013484. https:\/\/doi.org\/10.1007\/BF02231775 (1993).","journal-title":"Clin. Rheumatol."},{"issue":"1","key":"13650_CR11","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/nu9010006","volume":"9","author":"R Doggui","year":"2016","unstructured":"Doggui, R., El Ati-Hellal, M., Traissac, P., Lahmar, L. & El Ati, J. Adequacy assessment of a universal salt iodization program two decades after its implementation: A national cross-sectional study of iodine status among school-age children in Tunisia. Nutrients 9(1), 6. https:\/\/doi.org\/10.3390\/nu9010006 (2016).","journal-title":"Nutrients"},{"issue":"Suppl 6","key":"13650_CR12","doi-asserted-by":"publisher","first-page":"vi5","DOI":"10.1093\/rheumatology\/kes279","volume":"51","author":"J Kay","year":"2012","unstructured":"Kay, J. & Upchurch, K. S. ACR\/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology 51(Suppl 6), vi5\u2013vi9. https:\/\/doi.org\/10.1093\/rheumatology\/kes279 (2012).","journal-title":"Rheumatology"},{"issue":"5 Suppl 101","key":"13650_CR13","first-page":"S40","volume":"34","author":"PL van Riel","year":"2016","unstructured":"van Riel, P. L. & Renskers, L. The disease activity score (DAS) and the disease activity score using 28 joint counts (DAS28) in the management of rheumatoid arthritis. Clin. Exp. Rheumatol. 34(5 Suppl 101), S40\u2013S44 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"13650_CR14","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-015-0533-x","volume":"50","author":"XF Pan","year":"2015","unstructured":"Pan, X. F., Gu, J. Q. & Shan, Z. Y. Increased risk of thyroid autoimmunity in rheumatoid arthritis: A systematic review and meta-analysis. Endocrine 50(1), 79\u201386. https:\/\/doi.org\/10.1007\/s12020-015-0533-x (2015).","journal-title":"Endocrine"},{"key":"13650_CR15","doi-asserted-by":"publisher","first-page":"1015516","DOI":"10.3389\/fendo.2022.1015516","volume":"13","author":"YJ Liu","year":"2022","unstructured":"Liu, Y. J., Miao, H. B., Lin, S. & Chen, Z. Association between rheumatoid arthritis and thyroid dysfunction: A meta-analysis and systematic review. Front. Endocrinol. 13, 1015516. https:\/\/doi.org\/10.3389\/fendo.2022.1015516 (2022).","journal-title":"Front. Endocrinol."},{"issue":"3","key":"13650_CR16","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1097\/01.bor.0000160780.13012.be","volume":"17","author":"AH van der Helm-van Mil","year":"2005","unstructured":"van der Helm-van Mil, A. H., Wesoly, J. Z. & Huizinga, T. W. Understanding the genetic contribution to rheumatoid arthritis. Curr. Opin. Rheumatol. 17(3), 299\u2013304. https:\/\/doi.org\/10.1097\/01.bor.0000160780.13012.be (2005).","journal-title":"Curr. Opin. Rheumatol."},{"issue":"3","key":"13650_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/sj.gene.6364059","volume":"5","author":"Y Ban","year":"2004","unstructured":"Ban, Y. et al. Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves\u2019 disease. Genes Immun. 5(3), 203\u2013208. https:\/\/doi.org\/10.1038\/sj.gene.6364059 (2004).","journal-title":"Genes Immun."},{"issue":"1","key":"13650_CR18","doi-asserted-by":"publisher","first-page":"13235","DOI":"10.1038\/s41598-019-49743-4","volume":"9","author":"AS P\u00f6rings","year":"2019","unstructured":"P\u00f6rings, A. S., Lowin, T., Dufner, B., Grifka, J. & Straub, R. H. A thyroid hormone network exists in synovial fibroblasts of rheumatoid arthritis and osteoarthritis patients. Sci. Rep. 9(1), 13235. https:\/\/doi.org\/10.1038\/s41598-019-49743-4 (2019).","journal-title":"Sci. Rep."},{"issue":"6","key":"13650_CR19","doi-asserted-by":"publisher","first-page":"102529N","DOI":"10.1016\/j.autrev.2020.102529","volume":"19","author":"P Conigliaro","year":"2020","unstructured":"Conigliaro, P. et al. Autoimmune thyroid disorders and rheumatoid arthritis: A bidirectional interplay. Autoimmun. Rev. 19(6), 102529N. https:\/\/doi.org\/10.1016\/j.autrev.2020.102529 (2020).","journal-title":"Autoimmun. Rev."},{"key":"13650_CR20","doi-asserted-by":"publisher","first-page":"864907","DOI":"10.1155\/2012\/864907","volume":"2012","author":"J C\u00e1rdenas Rold\u00e1n","year":"2012","unstructured":"C\u00e1rdenas Rold\u00e1n, J. et al. Autoimmune thyroid disease in rheumatoid arthritis: A global perspective. Arthritis 2012, 864907. https:\/\/doi.org\/10.1155\/2012\/864907 (2012).","journal-title":"Arthritis"},{"issue":"2","key":"13650_CR21","first-page":"81","volume":"11","author":"WT El-Sherif","year":"2004","unstructured":"El-Sherif, W. T., El Gendi, S. S., Ashmawy, M. M., Ahmed, H. M. & Salama, M. M. Thyroid disorders and autoantibodies in systemic lupus erythematosus and rheumatoid arthritis patients. Egypt. J. Immunol. 11(2), 81\u201390 (2004).","journal-title":"Egypt. J. Immunol."},{"issue":"10","key":"13650_CR22","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/BF03346432","volume":"31","author":"H Nakamura","year":"2008","unstructured":"Nakamura, H. et al. Prevalence of interrelated autoantibodies in thyroid diseases and autoimmune disorders. J. Endocrinol. Invest. 31(10), 861\u2013865. https:\/\/doi.org\/10.1007\/BF03346432 (2008).","journal-title":"J. Endocrinol. Invest."},{"issue":"2","key":"13650_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.5114\/reum.2015.51504","volume":"53","author":"A Koszarny","year":"2015","unstructured":"Koszarny, A., Majdan, M., Dryglewska, M. & Tabarkiewicz, J. Prevalence of selected organ-specific autoantibodies in rheumatoid arthritis and primary Sj\u00f6gren\u2019s syndrome patients. Reumatologia 53(2), 61\u201368. https:\/\/doi.org\/10.5114\/reum.2015.51504 (2015).","journal-title":"Reumatologia"},{"issue":"5","key":"13650_CR24","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.berh.2019.01.021","volume":"32","author":"H Mahagna","year":"2018","unstructured":"Mahagna, H. et al. Rheumatoid arthritis and thyroid dysfunction: A cross-sectional study and a review of the literature. Best Pract. Res. Clin. Rheumatol. 32(5), 683\u2013691. https:\/\/doi.org\/10.1016\/j.berh.2019.01.021 (2018).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"issue":"12","key":"13650_CR25","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1089\/thy.2017.0715","volume":"28","author":"X Zhai","year":"2018","unstructured":"Zhai, X. et al. An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: A cross-sectional survey in China. Thyroid 28(12), 1571\u20131579. https:\/\/doi.org\/10.1089\/thy.2017.0715 (2018).","journal-title":"Thyroid"},{"issue":"1","key":"13650_CR26","doi-asserted-by":"publisher","first-page":"28487","DOI":"10.1097\/MD.0000000000028487","volume":"101","author":"CM Huang","year":"2022","unstructured":"Huang, C. M. et al. Hypothyroidism risk associated with rheumatoid arthritis: A population-based retrospective cohort study. Medicine 101(1), 28487. https:\/\/doi.org\/10.1097\/MD.0000000000028487 (2022).","journal-title":"Medicine"},{"issue":"1","key":"13650_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.9734\/JAMPS\/2016\/24689","volume":"7","author":"R Tekaya","year":"2016","unstructured":"Tekaya, R. et al. Relationship between autoimmune thyroid disorders and rheumatoid arthritis. J. Adv. Med. Pharm. Sci. 7(1), 1\u20136. https:\/\/doi.org\/10.9734\/JAMPS\/2016\/24689 (2016).","journal-title":"J. Adv. Med. Pharm. Sci."},{"issue":"6","key":"13650_CR28","doi-asserted-by":"publisher","first-page":"183567","DOI":"10.1001\/jamanetworkopen.2018.3567","volume":"1","author":"K Waldenlind","year":"2018","unstructured":"Waldenlind, K., Saevarsdottir, S., Bengtsson, C. & Askling, J. Risk of thyroxine-treated autoimmune thyroid disease associated with disease onset in patients with rheumatoid arthritis. JAMA Netw. Open 1(6), 183567. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3567 (2018).","journal-title":"JAMA Netw. Open"},{"issue":"43","key":"13650_CR29","doi-asserted-by":"publisher","first-page":"8357","DOI":"10.1097\/MD.0000000000008357","volume":"96","author":"A Emamifar","year":"2017","unstructured":"Emamifar, A., Hangaard, J. & Jensen Hansen, I. M. Thyroid disorders in patients with newly diagnosed rheumatoid arthritis is associated with poor initial treatment response evaluated by disease activity score in 28 joints-C-reactive protein (DAS28-CRP): An observational cohort study. Medicine 96(43), 8357. https:\/\/doi.org\/10.1097\/MD.0000000000008357 (2017).","journal-title":"Medicine"},{"issue":"2","key":"13650_CR30","doi-asserted-by":"publisher","first-page":"936","DOI":"10.21608\/ejhm.2020.103659","volume":"80","author":"S Hussein","year":"2020","unstructured":"Hussein, S., Mansour, H., Hussein, M., Abdel Aziz, A. & Aziz, N. Thyroid autoantibodies in Egyptian patients with autoimmune rheumatic diseases: Relation to disease activity and functional impairment. Egypt. J Hosp. Med. 80(2), 936\u2013942. https:\/\/doi.org\/10.21608\/ejhm.2020.103659 (2020).","journal-title":"Egypt. J Hosp. Med."},{"issue":"2","key":"13650_CR31","doi-asserted-by":"publisher","first-page":"491","DOI":"10.18203\/2320-6012.ijrms20190360","volume":"7","author":"M Waseem","year":"2019","unstructured":"Waseem, M. et al. Effect of thyroid dysfunction on disease activity of patients with rheumatoid arthritis. Int. J. Res. Med. Sci. 7(2), 491\u2013495. https:\/\/doi.org\/10.18203\/2320-6012.ijrms20190360 (2019).","journal-title":"Int. J. Res. Med. Sci."},{"issue":"6","key":"13650_CR32","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1590\/1516-3180.2017.0089110617","volume":"135","author":"RT Posselt","year":"2017","unstructured":"Posselt, R. T. et al. Prevalence of thyroid autoantibodies in patients with systematic autoimmune rheumatic diseases. Cross-sectional study. Sao Paulo Med. J. 135(6), 535\u2013540. https:\/\/doi.org\/10.1590\/1516-3180.2017.0089110617 (2017).","journal-title":"Sao Paulo Med. J."},{"issue":"1","key":"13650_CR33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1177\/0049475515627235","volume":"47","author":"P Joshi","year":"2017","unstructured":"Joshi, P., Agarwal, A., Vyas, S. & Kumar, R. Prevalence of hypothyroidism in rheumatoid arthritis and its correlation with disease activity. Trop. Doct. 47(1), 6\u201310. https:\/\/doi.org\/10.1177\/0049475515627235 (2017).","journal-title":"Trop. Doct."},{"key":"13650_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2167-7948.1000225","volume":"06","author":"M Nadeem","year":"2017","unstructured":"Nadeem, M., Khaliq, A., Bhat, M., Mustafa, F. & Mushtaqe, M. Spectrum of thyroid disorders in sero positive rheumatoid arthritis. J. Thyroid Disord. Ther. 06, 1\u20136 (2017).","journal-title":"J. Thyroid Disord. Ther."},{"key":"13650_CR35","unstructured":"Ghitany. Autoimmune thyroid disorders in seropositive versus seronegative rheumatoid arthritis (2015)."},{"issue":"2","key":"13650_CR36","doi-asserted-by":"publisher","first-page":"160","DOI":"10.2478\/rjim-2024-0002","volume":"62","author":"GD Karakili\u00e7","year":"2024","unstructured":"Karakili\u00e7, G. D., Borman, P., Kocao\u011flu, S., B\u00fcy\u00fck, F. & Bakirci, E. \u015e. Hypothyroidism and autoimmune thyroid disorders in rheumato\u0131d arthritis: Relationship w\u0131th disease activity. Rom. J. Int. 62(2), 160\u2013167. https:\/\/doi.org\/10.2478\/rjim-2024-0002 (2024).","journal-title":"Rom. J. Int."},{"key":"13650_CR37","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4103\/1110-161X.132458","volume":"41","author":"EA Elattar","year":"2014","unstructured":"Elattar, E. A., Younes, T. B. & Mobasher, S. A. Hypothyroidism in patients with rheumatoid arthritis and its relation to disease activity. Egypt Rheumatol. Rehabil. 41, 58\u201365. https:\/\/doi.org\/10.4103\/1110-161X.132458 (2014).","journal-title":"Egypt Rheumatol. Rehabil."},{"key":"13650_CR38","first-page":"151","volume":"14","author":"HA Azeem","year":"2019","unstructured":"Azeem, H. A., Alkabeer, A., Hashim, A. M., Rayan, M. M. & Ahmed, A. H. Study of prevalence of hypothyroidism in rheumatoid arthritis patients and its impact on disease severity. Int. J. Clin. Rheumatol. 14, 151 (2019).","journal-title":"Int. J. Clin. Rheumatol."},{"key":"13650_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.ejr.2018.08.002","volume":"41","author":"IM Saqre","year":"2019","unstructured":"Saqre, I. M., El-Bahnasawy, A. S., Farag, S.E.-D.M. & Bazeed, F. B. Autoimmune thyroid disease in Egyptian patients with rheumatoid arthritis. Egypt Rheumatol. 41, 167\u2013177 (2019).","journal-title":"Egypt Rheumatol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13650-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13650-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13650-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:59:00Z","timestamp":1759485540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-13650-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["13650"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-13650-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted according to the Declaration of Helsinki and the research protocol approved by the Ethics Committee of the Pasteur Institute of Tunis (No.2022\/9\/I).) and proved to be of no direct individual benefit. Helsinki Declaration has been followed for involving human subjects in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent statements"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"34491"}}